Tag Archives: lly

Lilly Drug Ramucirumab Boosts Lung Cancer Survival

Big pharma Eli Lilly (LLY) said Wednesday that its drug candidate ramucirumab improved the survival of lung-cancer patients in a late-stage study. Lilly stock gapped up 3% in early trading on the stock market today. The study looked at patients with metastatics non-small-cell lung cancer (NSCLC) who had failed a previous round of platinum-based chemotherapy. One group of patients took standard cancer drug docetaxel (best known as Sanofi’s (SNY)

Celgene Gets Good News On Two Cancer Drugs; Stock Up

Biotech Celgene (CELG) received a double dose of good news Tuesday as its drug Abraxane won a key approval in Europe, and partner Epizyme (EPZM) produced positive results on its leukemia drug. In early trading, Celgene stock was up 2%, near 165, while Epizyme’s vaulted 68% in the stock market today. The European Commission approved Abraxane combined with gemcitabine (better known as Eli Lilly’s (LLY) Gemzar) as a first-line treatment for